Aurobindo Pharma expands its presence in France with the launch of Arrow Pharma Production SAS for generic formulation manufacturing.
SENSEX 75,415.35
+ 231.99
NIFTY 23,719.30
+ 64.60
CRUDEOIL 9,363.00
Aurobindo Pharma reports Q4 net profit rise to ₹921 crore, driven by strong European market performance and overall revenue…
Aurobindo Pharma surpasses Dr Reddy's in FY26 revenue, becoming the second-largest Indian pharma company.
Aurobindo Pharma reports a 2% net profit rise to ₹921 crore with total revenue growing 5.6% to ₹8,853 crore in Q4.
The merger expands the combined entity’s manufacturing, research, and development capabilities, with a focus on specialty drugs…
Marksans Pharma to acquire Germany's ABCnow GmbH for €892,384, enhancing its European market presence and distribution…
GVRP and StepsBio establish a Bengaluru CoE for advanced formulations R&D, enhancing drug delivery systems and sterile…
Cenexi recovery, new product launches and capacity additions power Gland Pharma outlook
